IntrinsicIntrinsic
← Scroll for more →

biote Corp. (BTMD)

Medicinal Chemicals & Botanical Products

Latest Price
$1.21
TTM P/E
12.10
Normalized P/E
--
Div Yield
--
Book Value
--
P/B Ratio
--

Valuation metrics

adjust assumptions →
Norm. op. income: $29M (median of 5yr)
Tax rate: 19%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$2.62
+116% upside
Base FCF: $30M (median of recent 4yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$7.48
+518% upside
EPS: $0.74
Target P/E: 12×
Formula: EPS × P/E
P/E Fair Value
$8.88
+634% upside

Institutional Ownership

43.3% held by institutions
InstitutionSharesValueOwnership %ChangeFiling Date
325 Capital LLC4.55M$8.0M15.89%--2026-06-30
Bandera Partners LLC2.07M$3.0M7.22%--2026-06-30
Vanguard Capital Management LLC1.10M$2.0M3.85%-11.1K2026-06-30
Millennium Management LLC436.1K--1.52%+420.8K2026-06-30
Dimensional Fund Advisors LP432.0K--1.51%-111.5K2026-06-30
BlackRock, Inc.365.9K--1.28%-1.37M2026-06-30
Citadel Advisors LLC301.3K--1.05%+217.0K2026-06-30
Rice Hall James & Associates, LLC262.8K--0.92%+12.8K2026-06-30
Geode Capital Management, LLC260.5K--0.91%-355.2K2026-06-30
Jane Street Group, LLC253.3K--0.88%+203.9K2026-06-30
View all institutional holders →